New Edge Advisors, LLC Homology Medicines, Inc. Transaction History

New Edge Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.84 - $1.43 $840 - $1,430	-1,000 Reduced 68.49%	460 $0
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.12 $830 - $1,120	1,000 Added 217.39%	1,460 $1,000
Q1 2023 May 12, 2023	SELL	$0.91 - $1.69 $177 - $329	-195 Reduced 29.77%	460 $0
Q4 2022 Feb 14, 2023	BUY	$1.09 - $2.04 $713 - $1,336	655 New	655 $0

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.